[ARS] ABBOTT LABORATORIES SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

ARS

Rhea-AI Filing Summary

Analyzing...

03/13/2026 - 04:01 PM

ARS - ABBOTT LABORATORIES

ARS Filing - ABBOTT LABORATORIES

This filing is available as a PDF document.

Filing Type: ARS

Company: ABBOTT LABORATORIES (ABT)

Acceptance Date: 2026-03-13T16:01:48.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Abbott Labs

NYSE:ABT

View ABT Stock Overview →

ABT Rankings

#69 Ranked by Market Cap

#969 Ranked by Dividends

#1552 52-Week Gainer

#1629 YTD Gainer

#1047 Monthly Gainer

#1269 Ranked by Short %Change

ABT Latest News

Mar 23, 2026

Abbott completes acquisition of Exact Sciences

Mar 20, 2026

Abbott acquisition of Exact Sciences set to close on March 23, 2026

Mar 12, 2026

Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management

Mar 11, 2026

Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team'

Mar 5, 2026

Trial Set in NEC Multidistrict Litigation Against Reckitt Benckiser’s Mead Johnson Led by Levin Papantonio

ABT Latest SEC Filings

Mar 23, 2026

[8-K] ABBOTT LABORATORIES Reports Material Event

Mar 13, 2026

[DEF 14A] ABBOTT LABORATORIES Definitive Proxy Statement

Mar 9, 2026

[8-K] ABBOTT LABORATORIES Reports Material Event

Mar 3, 2026

[Form 4] ABBOTT LABORATORIES Insider Trading Activity

Mar 3, 2026

[Form 4] ABBOTT LABORATORIES Insider Trading Activity

ABT Stock Data

Market Cap 186.26B

Float 1.73B

Industry Medical Devices

Sector Pharmaceutical Preparations

Website Link

Country United States

City ABBOTT PARK